July 6, 2020 / 5:14 AM / a month ago

BRIEF-Obseva: Positive Results From Two Phase 3 Studies Of Yselty® (Linzagolix)

July 6 (Reuters) - OBSEVA SA:

* ANNOUNCES POSITIVE RESULTS FROM TWO PHASE 3 STUDIES, PRIMROSE 1 AND 2, OF YSELTY® (LINZAGOLIX) FOR TREATMENT OF UTERINE FIBROIDS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below